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Exercise intervention alters HDL subclass
distribution and function in obese women
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Abstract
Background: Obesity is associated with a change in high-density lipoprotein (HDL) function and subclass. Exercise
training reduces cardiovascular risk in obese patients. We aimed to explore the effect of an exercise training
stimulus on HDL functionality and subclass in obese women.
Methods: Thirty-two obese black South African women were randomly assigned to exercise (combined aerobic
and resistance exercise) or control (no exercise) conditions for 12-weeks. Pre- and post-testing included venous
blood sampling for analysis of lipid profile and HDL functionality, by measuring cellular cholesterol efflux capacity,
reduction in endothelial vascular cell adhesion molecule (VCAM) expression (anti-inflammatory function),
paraoxonase (PON) (antioxidative function) and platelet activating factor acetylhydrolase (PAF-AH) activities (anti-
thrombotic function). PON-1 and PAF-AH expression were determined in serum and in isolated HDL using Western
blotting. Levels of large, intermediate and small HDL subclasses were measured using the Lipoprint® system.
Results: Exercise training resulted in a decrease in body mass index (− 1.0 ± 0.5% vs + 1.2 ± 0.6%, p = 0.010), PON
activity (− 8.7 ± 2.4% vs + 1.1 ± 3.0%, p = 0.021), PAF-AH serum expression (− 22.1 ± 8.0% vs + 16.9 ± 9.8, p = 0.002),
and the distribution of small HDL subclasses (− 10.1 ± 5.4% vs + 15.7 ± 6.6%, p = 0.004) compared to controls.
Exercise did not alter HDL cellular cholesterol efflux capacity and anti-inflammatory function.
Conclusions: These results demonstrate the potential for exercise training to modify HDL subclass distribution and
HDL function in obese women.
Trial registration: Clinical trials number: PACTR201711002789113.
Keywords: Obesity, Exercise intervention, HDL structure, Cholesterol efflux, HDL subclass, Antioxidative, Anti-
inflammatory
Background
Approximately 23% of the worldwide burden of ischemic
heart disease can be attributed to obesity, with the preva-
lence of obesity doubling since 1980 [1]. Exercise is a
popular intervention designed to treat obesity and prevent
the onset of associated non-communicable diseases [2].
Indeed, exercise training interventions (aerobic and/or re-
sistance) reduce cardiovascular risk factors such as body
fat mass, blood pressure, total cholesterol, low-density
lipoprotein cholesterol (LDL-C) and raise high-density
lipoprotein cholesterol (HDL-C) [2–7]. As little as 30 min
of exercise per day can increase the concentration of
HDL-C in diabetic patients [8]. Although HDL-C concen-
trations are inversely associated with risk for cardiovascu-
lar disease [9], the recent outcomes of clinical trials aimed
at reducing the risk of cardiovascular disease (CVD) by in-
creasing HDL-C levels have been unsuccessful (reviewed
by [10]). Accordingly, there has been a significant shift in
focus from studying the quantity of HDL to studying the
quality [11–15]. HDL quality refers to specific HDL func-
tions and the distribution of HDL subclasses.
Although the principal function of HDL is reverse
cholesterol efflux/transport (RCT), HDL displays add-
itional physiological functions including antioxidative,
anti-inflammatory and anti-thrombotic activities. These
are mediated, at least in part, by HDL-associated
enzymes such as paraoxonase (PON) (antioxidative)
and platelet activating factor acetylhydrolase (PAF-AH)
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(anti-thrombotic) [16, 17]. HDL can also be subdi-
vided into several subclasses which display distinct
functionalities [18].
The African black population has low prevalence of
coronary artery and ischemic heart disease, which was
originally attributed to higher serum HDL-C [19].
Interestingly, studies highlight that HDL-C is the same
or even lower in black compared to white populations
[19–22]. A more recent study has further shown that
HDL functionality in African black women differed
from their white counterparts, with black women dis-
playing a higher level of HDL antioxidative function
[22]. These data support the notion that HDL quality,
rather than quantity may account for the difference in
prevalence of CVD between the white and black popu-
lations. Furthermore, exercise training may influence
HDL function [23]; however, the impact of exercise
training on HDL quality in a black population is still
unclear [23]. The aim of the study was to examine the
effects of exercise training on HDL functionality and
subclass, in obese black South African women.
Methods
Full methodology regarding recruitment and testing is
detailed by [24].
Participants
Forty-five women were recruited during 2015 and 2016
from the Western Cape, South Africa. Inclusion criteria
were: 20–35 years in age, obese (BMI 30–40 kg/m2),
weight stable for 6 months, black South African (both
biological parents isiXhosa), sedentary (not participating
in exercise training (< 1 session of < 20 min per week)
for a minimum of 12 months, on injectable contraceptive
(depot medroxyprogesterone acetate, 400 mg) for a mini-
mum of 2 months, no known illness or chronic disease,
not taking any medications, and had no surgical proce-
dures within the last 6 months. This study was approved
by the Human Research Ethics Committee at the Univer-
sity of Cape Town (HREC REF: 054/2015), complies with
Declaration of Helsinki principles and participants pro-
vided written consent prior to testing. Clinical trials num-
ber: PACTR201711002789113.
Study design
Participants were block randomized into either control
(n = 22) or exercise (n = 23) conditions (Additional file 1:
Figure S1). Thirty-five women in control (n = 15) and
exercise (n = 20) groups completed the study. The exer-
cise intervention consisted of 12 weeks of supervised
aerobic and resistance exercise training of moderate-
vigorous intensity for 40 to 60 min, 4 days per week by
a trained exercise physiologist. Exercises included car-
diovascular exercises in the form of aerobic dance,
running, skipping, and stepping that were performed
at a moderate-vigorous intensity (75–80% peak heart
rate, HRpeak). Resistance exercises included the partici-
pants using their own body weight and progressed to
the use of equipment (eg bands and free weights).
These exercises included squats, lunges, bicep curls,
push-ups and shoulder press with a prescribed inten-
sity of 60% to 70% HRpeak. Participants wore a heart
rate monitor (Polar A300, Kempele, Finland) during
all training sessions to ensure the prescribed intensity
was maintained throughout the 12-week period. The
control participants were instructed to continue their
normal physical activity and dietary patterns. Partici-
pants attended two pre- and two post-intervention
testing sessions. The first session comprised of anthro-
pometry and a graded exercise test for the assessment
of peak oxygen consumption (VO2peak) and peak heart
rate (HRpeak). After a minimum of 48-h recovery from
the previous testing session, participants returned for
fasting (10–12 h) venous blood collection for analysis
of total cholesterol (total-C), low-density lipoprotein
cholesterol (LDL-C), HDL-C concentration, HDL
functionality and subclass distribution.
Nutritional and physical activity standardization
The exercise and control groups were instructed to
maintain their usual dietary intake. The control group
was also instructed to continue their habitual physical
activity and to refrain from initiating any exercise pro-
gram. Prior to the start of all testing sessions, partici-
pants refrained from any physical activity for a
minimum of 48 h, and from consumption of alcohol
and caffeine for 24 h.
Anthropometry and graded exercise test
Anthropometric measures included stature, body mass,
waist (at level of umbilicus) and hip girths (greatest protru-
sion of buttocks) using standard techniques [25]. These
measures were used to calculate body mass index (BMI)
and the waist-to-hip ratio (WHR). VO2peak and HRpeak
(Polar A300, Kempele, Finland) were measured using a
treadmill-based (C, Quasar LE 500 CE, HP Cosmos,
Nussdorf-Traunstein, Germany) graded exercise test. This
walking cardiorespiratory fitness test was designed for par-
ticipants whom were sedentary and unfamiliar with
gym-based equipment. Pulmonary gas exchange was mea-
sured by determining O2 and CO2 concentrations and ven-
tilation to calculate VO2 consumption using a metabolic
gas analysis system (CPET, Cosmed, Rome Italy). Prior to
each test, the gas meter was calibrated with a 3-l syringe
(Vacumed, Ventura, CA), and analyzers calibrated using
standard gas mixtures of oxygen (26% O2 with the balance
nitrogen) and carbon dioxide (4% CO2, 16% O2 and the
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balance nitrogen; BOC Special Gas, Afrox Cape Town,
South Africa).
Venous blood collection and lipid profile
Fasting (10–12 h) venous blood samples were col-
lected in serum separating tubes (SST) and clotted for
15–30 min at room temperature. Samples were centri-
fuged at 3000 rpm for 10 min at 4 °C. Serum was im-
mediately stored at − 80 °C until further analyses.
Serum lipid profile (HDL-C, LDL-C and Total-C) was
determined using a colorimetric assay (Randox (Pty)
Ltd., Gauteng, South Africa).
HDL isolation
HDL was isolated from aliquots of serum using ultracen-
trifugation, as previously described [26, 27]. Purity was
confirmed using 12.5% reducing SDS-polyacrylamide gel
electrophoresis (PAGE) stained with Coomassie Blue.
The protein concentration of HDL was determined by
the modified Lowry method [28] All samples were
analysed in duplicate.
Quantification of HDL anti-inflammatory function
HDL anti-inflammatory function was measured using a
cell culture model as previously described [27]. Briefly,
human umbilical vein endothelial cells (HUVEC) were
serum deprived prior to treatment with 10 μg/ml of iso-
lated HDL for 30 min. Eight participants per group
were randomly selected (Additional file 1: Figure S1).
Cells were then stimulated with 20 ng/ml murine
tumour necrosis factor alpha (TNF-α) (PeproTech,
315-01A) for 5 h. Following RNA isolation and cDNA
synthesis, cDNA was amplified for 25 cycles using the
RT2 SYBR Green qPCR kit (Qiagen, 330,500) in the
RotorGene6000 (Corbit Lifesciences) to quantify ex-
pression levels of VCAM and GAPDH. Data is pre-
sented as relative reduction in VCAM expression
compared to an untreated control.
Quantification of HDL cellular cholesterol efflux capacity
HDL induced cholesterol efflux was quantified using a
modified method [29]. Briefly, RAW264.7 cells, generously
donated by Prof Gil Dealtry (Nelson Mandela Metropol-
itan University), were proliferated in RPMI-1640 media
(Sigma, R8758) supplemented with 10% foetal calf serum
and penicillin/streptomycin prior to seeding (100,000
cells/well) in 24-well culture plates for 16 h. Labelling
medium was prepared by adding 4 μCi/ml of [3H] choles-
terol (Perkin Elmer, NET139001MC) to RPMI-1640
medium containing 2 μg/ml of acyl-CoA cholesterol acyl-
transferase (ACAT) inhibitor (Sandoz, Sigma, S9318) and
supplemented with 5% foetal calf serum. Cells were then
incubated in labelling medium for 24 h. Cells were washed
with minimum essential eagle medium (MEM) in HEPES
buffer prior to addition of 25 μg/ml of isolated HDL in
MEM-HEPES for 4 h. Cell culture media was extracted
and added to Ultima Gold scintillant (Perkin Elmer,
6,013,327). Counts per minute (CPM) were enumerated
using TriCarb® Liquid Scintillation Analyzer and QuantaS-
martTM software with 2 Sigma terminator 0.5 and 30 min
count time. Cellular cholesterol efflux capacity was calcu-
lated as label present in the cell media relative to the un-
treated control.
Paraoxonase (PON) activity
Serum paraoxonase activity was measured as previ-
ously described [27]. Serum samples were diluted 1:10
in phosphate buffer containing 2 mM CaCl2 (pH 8).
Diluted serum was added to 96-well plates in tripli-
cate and paraoxon-ethyl substrate (Sigma, D9286) was
added. Absorbance at A405 was measured at 30 s in-
tervals over 20 min. One Unit of activity is defined as
1 nmol of substrate hydrolysed per min.
Platelet activating factor Acetylhydrolase (PAF-AH)
activity
PAF-AH activity was measured in participant sera as previ-
ously described [27], using the PAF Acetylhydrolase Assay
Kit (Cayman Chemical, 760,901). Briefly, serum was added
to an equal volume of 5, 5′-dithio-bis-(2-nitrobenzoic acid)
(DTNB; Ellman’s Reagent) and assay buffer in triplicate into
clear 96-well plates. All wells were incubated with 2-thio
PAF substrate and absorbance at A412 measured at 1 min
time intervals for 20 min. One Unit of activity is defined as
1 μmol of substrate hydrolysed per min.
PON-1 and PAF-AH expression
Isolated HDL and serum samples from each of the par-
ticipants were electrophoresed on reducing 12.5% SDS-
polyacrylamide (SDS-PAGE) gels with 1.5 μg of HDL
protein or 8 μg of serum loaded per well. Samples were
run over three separate gels with control samples re-
peated in each gel. Blots were transferred onto nitrocel-
lulose membranes (Bio-Rad, 162–0113). Ponceau S
staining was scanned and used to validate equal loading
of wells. Blots were blocked in 5% low fat milk powder
in 0.05% Tween in Tris-buffered Saline (TTBS, pH 7.5)
and incubated overnight in primary mouse anti-PON-1
antibody (1:200) [26] and rabbit anti-PAF-AH (1:400)
(Cayman Chemical, 160,603). Blots were then washed
in TTBS and incubated in goat anti-mouse-HRP conju-
gated secondary antibody (1:5000) (Bio-Rad, 170 6516)
and goat anti-rabbit-HRP conjugated secondary anti-
body (1:2500) (Santa Cruz Biotechnology, sc-2313), re-
spectively for 1 h at room temperature. Blots were
thoroughly washed in TTBS prior to incubation in
Amersham TM ECL™ Western blotting detection re-
agent (GE Healthcare, RPN2106). Blots were captured
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in the GeneGnome gel imager. Densitometry of PON-1
and PAF-AH blots was quantified using Quantity one soft-
ware. PON-1 and PAF-AH relative expression data were
corrected for control samples, repeated in each gel.
Quantification of HDL subclass distribution
Serum HDL subclass was determined using the Lipo-
print® HDL system (Quantimetrix, Redondo Beach, CA)
as previously described [27]. Briefly, serum (25 μl) was
mixed with Lipoprint loading gel, containing Sudan
black dye which binds proportionally to the cholesterol
present in the sample. The mix was placed onto the
upper part of the high resolution 3% polyacrylamide
gel. Photopolymerisation was carried out for 30 min at
room temperature and electrophoresis was performed
for 50–60 min at 3 mA per gel tube. After a rest period
of 30 min, gel tubes were scanned and analysed using
the Lipoware software. For HDL subclass, the very
low-density lipoprotein (VLDL) and LDL remained at
the origin [Retention Factor (Rf ) = 0.0] and is shown as
a grey peak to the left of the large HDL subclass distri-
bution profile while albumin migrated as the leading
front (Rf = 1.0). Between these, 10 HDL bands could be
detected. HDL-1, HDL-2 and HDL-3 were defined as
large HDL; HDL-4, HDL-5, HDL-6 and HDL-7 were
defined as intermediate HDL and HDL-8, HDL-9 and
HDL-10 were defined as small HDL. Each subclass was
quantified and expressed as a percentage of total HDL.
Statistical analysis
Results are presented as mean or as percentage changes
relative to baseline ± standard error of mean (SEM).
Non-normally distributed data were log transformed prior
to statistical analysis and included LDL-C, serum PON-1,
serum and HDL PAF-AH expression. Non-normally
distributed data are presented as medians ± interquartile
range (IQR). Sample size determination was based on pre-
vious studies regarding exercise training interventions in
obese individuals [10, 30], using a significance level of p
< 0.05 and power of 80%, as described in detail previously
[24]. Two-way repeated measures analysis of variance was
used to compare changes in anthropometry, VO2peak,
lipids, cholesterol efflux capacity, anti-inflammatory func-
tion, paraoxonase activity, PAF-AH activity and HDL sub-
class distribution between groups over the 12-week
period, followed by Fischer post-hoc testing. Pearson cor-
relation coefficients for the associations between anthro-
pometry, VO2peak, HDL-C, HDL function and subclass
were determined at baseline and changes in the combined
sample. Where appropriate, statistical analysis were ad-
justed for patient BMI. p < 0.05 was deemed statistically
significant and statistical tests were performed using Sta-
tistica (Version 13.2, Dell Inc., 2016).
Results
Changes in anthropometry, cardiorespiratory fitness and
lipids
Adherence to the exercise training, expressed as the
percentage attendance of total number of sessions, was
80.3 ± 3.0% (range: 60.4–100%). Exercise training re-
sulted in a significant increase in cardiorespiratory fit-
ness (VO2peak) compared to control (p = 0.003 for
interaction, Table 1). BMI, body weight, waist and hip
circumference and waist/hip ratio (WHR) decreased in
response to the 12-week intervention in the exercise
group compared to the controls (p < 0.05 for inter-
action). Total-C, HDL-C and LDL-C concentrations did
not vary between groups in response to the interven-
tion (p = 0.141, p = 0.238 and p = 0.202 for interaction,
Table 1 Changes in anthropometry, cardiorespiratory fitness and lipid profile in response to the 12-week intervention
Control (n = 15) Exercise (n = 20) p value
Pre-testing Post-testing Pre-testing Post-testing Group Time Interaction
Age (yrs) 24.5 ± 0.9 22.8 ± 0.7 0.157 – –
BMI (kg/m2) 33.3 ± 0.8 33.7 ± 0.8 34.4 ± 0.6 34.0 ± 0.7 0.493 0.678 0.010
Body weight (kg) 88.0 ± 3.2 89.1 ± 3.2* 84.1 ± 1.9 83.3 ± 2.2 0.187 0.681 0.007
Waist circumference (cm) 103 ± 2 106 ± 2* 104 ± 2 100 ± 2** 0.406 0.548 0.001
Hip circumference (cm) 118 ± 2 119 ± 2 114 ± 1 113 ± 1* 0.045 0.359 0.022
WHR 0.88 ± 0.01 0.89 ± 0.02 0.91 ± 0.01 0.89 ± 0.01 0.436 0.892 0.044
Total-C (mmol/L) 3.91 ± 0.35 3.65 ± 0.35 3.98 ± 0.18 4.27 ± 0.21 0.299 0.917 0.141
LDL-C (mmol/L) 1.94 ± 0.29 1.57 ± 1.43 2.80 ± 0.99 2.69 ± 1.34 0.169 < 0.001 0.202
HDL-C (mmol/L) 0.97 ± 0.06 0.97 ± 0.06 1.00 ± 0.05 1.05 ± 0.04 0.343 0.511 0.568
VO2peak (ml/kg/min) 23.7 ± 0.8 22.7 ± 0.9 25.2 ± 0.7 27.7 ± 0.7* 0.002 0.202 0.003
Results represent means ± SEM and as medians ± IQR for LDL-C. Unadjusted p values testing for significance of the grouping variable (Control vs Exercise), time
(intervention duration) and the interaction (Group*Time). For Fischer post-hoc testing following interaction effect: * p < 0.05 ** p < 0.005 pre vs post-testing. BMI
Body mass index, WHR Waist/hip ratio, Total-C Total-cholesterol, LDL-C Low-density lipoprotein, HDL-C High-density lipoprotein and VO2peak, Peak
oxygen consumption
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respectively), while there was a decrease in LDL-C over
time in both groups (p < 0.001 for time).
Shift in HDL subclass distribution
The distribution and percent change of HDL subclasses
in response to the exercise intervention are presented
in representative scan sections of large, intermediate
and small subclass distributions (Fig. 1). At baseline,
the distribution of large, intermediate and small HDL
subclasses were not different between the control and
exercise groups (28.4 ± 2.2% vs 26.4 ± 1.8%, p = 0.803;
59.5 ± 1.4% vs 58.5 ± 1.0%, p = 0.701; and 11.8 ± 1.5% vs
15.0 ± 1.4%, p = 0.112, respectively). The distribution of
large HDL subclasses did not change in response to the
intervention (p = 0.105 for interaction), while the
distribution of small HDL subclasses decreased in the
exercise group compared to controls (p = 0.004 for
interaction). When correcting for the change in BMI,
this effect was maintained (p = 0.040 for interaction).
The distribution of intermediate HDL subclasses was
similar between groups in response to the intervention
(p = 0.523 for interaction).
Changes in HDL function
At baseline, cholesterol efflux capacity did not differ
between control and exercise groups (3.77 ± 0.22 vs
3.63 ± 0.20 AU, p = 0.808, respectively). HDL-mediated
cholesterol efflux capacity did not change in response
to a 12-week exercise intervention (p = 0.524 for inter-
action, Fig. 2a). At baseline HDL anti-inflammatory
function (expressed as relative reduction in VCAM ex-
pression in HUVEC cells) did not differ between con-
trol and exercise groups (0.47 ± 0.07 vs 0.50 ± 0.09 AU,
p = 0.504, respectively, Fig. 2b) and did not change in
response to a 12-week exercise intervention (p = 0.516
for interaction).
At baseline, serum PON activity did not differ be-
tween the control and the exercise groups (0.90 ± 0.07
vs 0.83 ± 0.05 U/L, p = 0.173, respectively). After
12 weeks, serum PON activity decreased in response
to the exercise intervention only (p = 0.021 for inter-
action, Fig. 3a), even after adjusting for the change in
BMI (p = 0.006 for interaction). In contrast, serum and
HDL PON-1 expression did not differ at baseline be-
tween groups (p = 0.751 and p = 0.464, respectively,
A D G
B E H
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Fig. 1 Distribution of HDL subclasses in participant sera in response to the intervention. Participant sera was analysed using the Lipoprint® system
and analysed using Lipoware software. Representative scan results of control (a, d and g) and exercise (b, e and h) sera pre and post testing.
Representative scan results (a, b, d, e, g and h). Changes in the percentages of large ©, intermediate (f) and small (i) HDL subclasses. VLDL,Very
low density lipoprotein. Results are means ± SEM .** p < 0.005 significance for interaction
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Fig. 3b-e) or in response to the intervention (p = 0.888
and p = 0.697 for interaction, respectively). The associ-
ation between PON activity and expression was ex-
plored at baseline in all participants and serum PON
activity were positively correlated with serum and
HDL PON-1 expression (r = 0.48, p = 0.016, and r = 0.57,
p = 0.001, respectively). However, percentage change in
PON activity was not associated with change in serum
and HDL PON-1 expression (r = − 0.05, p = 0.817, and
r = 0.09, p = 0.633, respectively).
At baseline, serum PAF-AH activity did not differ be-
tween the control and the exercise groups (12.7 ± 1.4 vs
15.2 ± 1.2 U/L, p = 0.311, respectively). There was no differ-
ence in PAF-AH activity between groups in response to the
intervention (p = 0.112 for interaction, Fig. 4a). In contrast,
serum PAF-AH expression decreased in response to the
exercise intervention compared to controls (p = 0.002 for
interaction, Fig. 4d). This effect in the exercise group was
maintained when correcting for the change in BMI (p
= 0.003 for interaction). However, changes in HDL
PAF-AH expression were not different between groups
over time (p = 0.493 for interaction). No associations were
found between PAF-AH activity and serum and HDL
PAF-AH expression at baseline (r = 0.02, p = 921, and r =
0.09, p = 681, respectively) or between changes in activity
and expression over the 12-week intervention (r = 0.38,
p = 0.055, and r = 0.17, p = 0.441, respectively).
Relationships between anthropomorphic measures,
cardiorespiratory fitness and HDL function and subclass
At baseline, higher BMI was associated with lower choles-
terol efflux capacity (r = − 0.42, p = 0.024) and less large
HDL subclasses (r = − 0.37, p = 0.041, Additional file 1:
Table S1). There were no associations between the changes
in aerobic capacity, body composition, and HDL-C and
changes in HDL function. However, a decrease in WHR in
the combined sample over the twelve-week period, was as-
sociated with an increase in the percentage of large HDL
subclasses (r = − 0.39, p = 0.035 Fig. 5b).
Relationships between measures of HDL functionality
with HDL subclass
At baseline, reverse cholesterol efflux was positively as-
sociated with anti-inflammatory function (r = 0.68, p= 0.016,
Additional file 1: Table S1). Similarly, higher HDL anti-in-
flammatory function was associated with a greater percent-
age of large HDL and lower percentage of intermediate
HDL subclasses (r = 0.53, p= 0.049 and r= − 0.54, p= 0.043,
respectively, Fig. 5a). In all participants, an increase in PON
activity, over the twelve-week period, was associated with an
increase in the percentage of small HDL subclasses (r = 0.51,
p= 0.004, Fig. 5c).
Discussion
This study aimed to explore whether exercise training
results in the modification of HDL functionality and HDL
subclass distribution. Although HDL-C concentrations
were unchanged, the 12-week exercise training interven-
tion in obese black South African women resulted in a
reduction in PON activity, serum PAF-AH expression and
percentage of small HDL subclasses. For the first time, we
provide evidence to suggest that exercise training may
revert HDL subclass distribution back to a “non-obese”
state in a black South African population.
A B
Fig. 2 Changes in reverse cholesterol efflux capacity and anti-inflammatory function in response to the intervention. [3H-Cholesterol] was effluxed
from RAW264.7 cells for 4 h prior to scintillation counting. Cholesterol efflux capacity represents the mean radiolabel present in culture media
relative to that of an untreated control (a). HUVEC cells were treated with 10 μg/ml participant HDL prior to 20 ng/ml tumour necrosis factor
(TNF) treatment for 8 h. Results are calculated relative to a no-HDL treatment control (b). Cell lysates were harvested and stored in RNAprotect
reagent prior to RNA extraction, followed by cDNA synthesis and quantitative real time PCR. Results as percentage changes relative to a baseline.
Results are means ± SEM. VCAM, Vascular Cell Adhesion Molecule
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Fig. 3 Changes in paraoxonase activity and protein expression in response to the intervention. Paraxonase activity of diluted sera was measured
at A405 over a 20 min time interval using the paraoxon-ethyl substrate. One unit of activity is defined as 1 nmol of substrate disintegrated per
minute (a). Participant sera (b and d) and isolated HDL (c and e) were run on reducing 12.5% SDS-PAGE gels and transferred to nitrocellulose
membrane. Ponceau S staining was used to confirm equal loading. Blots were probed with mouse anti-PON-1 antibody. Results are representative of
randomized experiments (b) and (c). Results are presented as percentage changes in densitometry relative to a baseline in sera (d) and HDL (e). Results
are means ± SEM.* p < 0.05 significance for interaction. PON, Paraoxonase
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Fig. 4 Changes in PAF-AH activity and protein expression in response to the intervention. PAF-AH activity of diluted sera was measured at A412
over a 20 min time interval using the PAF Acetylhydrolase Assay Kit. One unit of activity is defined as 1 μmol of substrate disintegrated per
minute (a). Participant sera (b and d) and isolated HDL (c and e) were run on reducing 12.5% SDS-PAGE gels and transferred to nitrocellulose
membrane. Ponceau S staining was used to confirm equal loading. Blots were probed with rabbit anti-PAF-AH antibody. Results are representative of
randomized experiments (b) and (c). Results are presented as percentage changes in densitometry relative to a baseline in sera (d) and
HDL (e).** p < 0.005 significance for interaction. PAF-AH, Platelet activating factor acetylhydrolase
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Exercise interventions are routinely prescribed for obese
individuals with the aim of reducing the risk of cardio-
metabolic complications, and have been shown to pro-
mote an increase in HDL-C concentration [8, 31, 32]. To
our knowledge, this is the first study to examine the ef-
fects of exercise training on HDL-C concentrations in a
black African population, who present with lower HDL-C
levels compared to other populations [19, 21]. However,
the current study did not find any change in HDL-C fol-
lowing the intervention. Despite no changes in HDL-C
concentrations, the exercise intervention resulted in a sig-
nificant decrease in small HDL subclasses.
A previous study in black South African women re-
ported that obesity was associated with lower levels of
large and high levels of smaller HDL subclasses, com-
pared to normal-weight subjects [27]. In the current
study, a statistically significant change in body compos-
ition (BMI and WHR) following an exercise intervention
was observed, however, these changes were minimal.
Critically, when adjusting for the changes in BMI and
WHR, the exercise training adaptations in HDL subclass
were maintained. This suggests that changes in HDL
subclass were potentially mediated by the stimulus of
the exercise intervention and not necessarily through a
change in body composition. These results are supported
by other exercise intervention studies which have also
shown that exercise training resulted in changes in HDL
subclasses, favouring increases in larger HDL subclasses,
that were accompanied by non-significant changes in
BMI [33–36]. These results collectively suggest that ex-
ercise training may stimulate additional mechanisms
which may cause shifts in HDL subclass, independent of
changes in body composition.
There is a significant debate in the literature regard-
ing the contributions of each of the HDL subclasses to
overall HDL functionality. It is also important to con-
sider that nomenclature for HDL subclass depends on
the methods used for quantification and separation
[37]. This study designates HDL subclasses as large,
intermediate and small as quantified by the Lipoprint®
System. Much of the existing literature describes two
principal HDL subclasses, the larger, HDL2 and smaller
HDL3 [38, 39]. Whilst epidemiological studies describe
lower HDL2 levels as an inverse predictor for cardio-
vascular disease, pre-clinical studies describe the bene-
fits of increased HDL3 owing to a higher association
with cardioprotective proteins and lipids, as reviewed
by [10]. Therefore, while the results from this study are
consistent with other studies in the literature, it is diffi-
cult at this stage to affirm whether the decrease in
small HDL subclasses is of benefit to overall risk of
CVD. This requires further investigation.
Common mechanisms stimulated by exercise training, in-
cluding reductions in oxidative stress and inflammation
[40, 41], may be contributing factors to the shift in HDL
subclass, observed in the current study. The exercise inter-
vention resulted in a decrease in the antioxidative activity
of PON and the serum expression of PAF-AH, respectively.
This is in contrast to other studies that found improve-
ments in PON activity and overall HDL antioxidant func-
tion after moderate aerobic exercise interventions (3 or
4 months) in metabolic syndrome and type 2 diabetic pa-
tients, respectively [35, 36]. The unexpected PON activity
results in the present study may be explained by the partici-
pants being normolipidemic and nondiabetic prior to the
intervention, and/or differences in the type and intensity of
the exercise intervention. PON activity is largely modulated
by genetic and environmental factors such as smoking and
intake of antioxidants, and these factors may also contrib-
ute to differences between studies [35, 36, 42]). Indeed,
studies in overweight adolescents and type 2 diabetic pa-
tients have reported that exercise training interventions
may reduce oxidative stress and the potential risk of
CVD [43]. This suggests that the beneficial aspects of exer-
cise training may result in a compensatory reduction in
PON activity owing to reduction in oxidative stress.
HDL not only controls oxidative stress but also per-
forms several anti-inflammatory functions [17]. Here,
A B C
Fig. 5 Associations between HDL subclass, function and changes in body composition in response to the 12-week intervention. Baseline HDL
anti-inflammatory function is plotted against baseline large HDL subclass distribution (a). Changes in WHR (b) are plotted against changes in
large HDL subclass percentage. Changes in HDL function (PON activity (c)) are plotted against changes in small HDL subclass percentages. Values
represent Pearson correlation coefficients. AU, Arbitrary units; WHR, Waist/hip ratio and PON, Paraoxonase
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the exercise intervention did not improve HDL anti-in-
flammatory function. In contrast, only one other study
has explored how a 21-day dietary and exercise inter-
vention in obese men (which resulted in a 3.2% de-
crease in BMI), improved HDL anti-inflammatory
function [35]. Despite a low sample size, our data do
not support an association between changes in BMI or
WHR with a change in anti-inflammatory function. In
addition, the minimal changes in body composition ob-
served in the current study may indeed suggest that sub-
stantial changes in body composition may be required to
influence changes in HDL anti-inflammatory function.
The current study showed that exercise training stimu-
lated a decrease in the serum expression of PAF-AH. Previ-
ous literature has reported increased PAF-AH activity in
response to a short term (3 weeks) diet and exercise inter-
vention in obese participants [44]. This suggests that diet
and exercise-based interventions stimulate different mecha-
nisms of PAF-AH activity, which may be specific to weight
loss, changes in body composition and/or change in diet
quality. In the current study, there were no associations be-
tween changes in PAF-AH activity and expression with
changes in BMI and WHR. Furthermore, participants did
not display a substantial change in weight, thus the decrease
in PAF-AH expression may relate to other mechanisms spe-
cifically associated with an exercise training stimulus; how-
ever, further research is required in this area. The lack of a
significant correlation between HDL and serum PAF-AH
expression may further explain this disparity.
Cholesterol efflux capacity is considered to be the pri-
mary function of HDL in vivo and this did not change fol-
lowing the 12-week intervention. These results are
consistent with previous studies conducted in African
American populations where a 6 month diet programme
of reduced fat and energy, combined with low-intensity
exercise, showed improvements in fitness and weight loss,
but no changes in cholesterol efflux capacity [45]. Baseline
results of the current study showed that cholesterol efflux
capacity was associated with a lower WHR. Similarly, a
study, examining the relationship between body compos-
ition and HDL cholesterol efflux, indicated that an in-
crease in waist circumference was an accurate predictor of
impairment in cholesterol efflux capacity [46]. Previously,
an association between increased BMI and lower choles-
terol efflux capacity has been shown in obese subjects
[47]. Commensurate with these findings, improvement in
cholesterol efflux capacity in individuals undergoing exer-
cise interventions were only significant in those individ-
uals with significant weight loss [48]. Accordingly, the lack
of clinically significant changes in body composition in
our study may explain the lack of change in HDL choles-
terol efflux capacity in response to the intervention.
The present study highlights that HDL function and
subclass may be modified concurrently in response to
exercise training. Accordingly, it is recommended that
both HDL function and subclass are considered when
assessing changes in CVD risk in response to an exercise
training intervention. We report an association between
a decrease in small HDL subclasses and a decrease in
PON activity. PON is preferentially associated with
smaller HDL subclasses, therefore suggesting that a de-
crease in PON activity is associated with a decrease in
the distribution of small HDL subclasses [49]. HDL sub-
classes have inherent functional differences; however,
few studies have considered the associations between
HDL size and function and have not done so using the
Lipoprint® System. Therefore, this study presents novel
findings that changes in traditional measures of HDL
function can be linked to new measures of HDL size.
Notably, this study has limitations that must be consid-
ered. In particular, this study was limited with a relatively
small sample size. Whilst cholesterol efflux measurements
were performed using biological triplicate measurements
for each participant, due to technical constraints, the
anti-inflammatory assay was only able to be performed on
8 participants. Furthermore, other clinical studies nor-
mally employ J744 macrophage cells to test cholesterol ef-
flux capacity. RAW264.7 cells were optimized for the
conditions employed in this study and produced reprodu-
cible results and therefore presented an applicable model.
There was, however, good adherence to the exercise train-
ing, thus allowing for adequate interpretation of its effects
on HDL function and subclass distribution.
Conclusion
Despite no change in HDL-C concentrations, our study
presents novel findings that exercise training may revert
the HDL subclass distribution to a “non-obese” state in
obese black women. Furthermore, exercise training al-
tered HDL antioxidative and anti-thrombotic function,
independent of changes in body composition. This study
provides novel evidence on the association between
HDL function and subclass distribution in a black Afri-
can population, suggesting that studying HDL subclass
and function may be a sensitive approach to assess CVD
risk in this population compared to the measurement of
HDL-C levels alone.
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